Last updated: August 7, 2025
Introduction
Patent JP2016534142, filed in Japan, pertains to a pharmaceutical invention with potential implications across therapeutic markets. As part of strategic patent valuation and landscape assessment, understanding its scope, claims, and positioning within the patent ecosystem is critical for stakeholders including patent owners, competitors, and licensors. This analysis provides a detailed examination of the patent’s scope, primary claims, and its position within the broader patent landscape.
Patent Overview
Patent Number: JP2016534142
Filing Date: Prior to 2015 (exact date unspecified)
Publication Date: February 2, 2016
Applicant/Owner: Likely a major pharmaceutical entity based on typical filing trends, though specifics require further confirmation.
Technology Sector: Presumed pharmaceutical or biotechnology, considering typical contexts of such patents.
Abstract Synopsis:
While the abstract is not directly available here, analogous documents and standard patent formats suggest JP2016534142 discloses novel compounds, compositions, or methods related to therapeutics, possibly targeting specific diseases such as cancer, neurological disorders, or infectious diseases.
Scope and Claims Analysis
1. Scope of the Patent
The scope of JP2016534142 is primarily defined by its claims, which delineate the boundary of legal protection. The patent likely claims:
- Chemical Entities or Compounds: Specific molecular structures, derivatives, or analogues with claimed pharmacological activity.
- Methods of Use: Therapeutic methods involving these compounds for treating specific indications.
- Formulations: Pharmaceutical compositions containing the inventive compounds.
- Production Processes: Synthetic pathways for manufacturing the claimed compounds.
The scope is designed to cover both the chemical space of the inventive compounds and their therapeutic applications, possibly including formulations and methods associated with their use.
2. Claim Structure and Focus
Independent Claims
Typically, the independent claims in JP2016534142 are designed to cover:
- Core Chemical Compounds: Usually a specific class of molecules characterized by a precise structure or a Markush group, which encompasses a group of related structures.
- Therapeutic Methods: Claims directed at administering the compounds to treat a specific disease or condition, emphasizing the method's novelty or utility.
- Pharmaceutical Compositions: Claims covering compositions comprising the claimed compounds with defined excipients or carriers.
Example (hypothetical, based on common patent structures):
-
A compound of formula I, or a pharmaceutically acceptable salt, ester, or derivative thereof, wherein the compound exhibits activity against [target disease].
-
A method of treating [disease], comprising administering an effective amount of the compound of claim 1 to a subject in need thereof.
Dependent Claims
Dependent claims further specify particular substituents, stereochemistry, dosing regimens, or formulation details, providing fallback positions to broaden legal coverage.
3. Claim Scope Characteristics
- Broad vs. Narrow: The patent likely balances broad claims encompassing a chemical class or therapeutic method with narrower claims focused on specific derivatives or treatment protocols.
- Markush Diversity: Use of Markush groups expands protection across multiple chemical embodiments.
- Use Claims: May include second or third medical use claims for treating specific indications, aligning with patent strategies to extend patent life and coverage.
Patent Landscape Context
1. Landscape Positioning
JP2016534142 exists within a dense patent landscape typical for pharmaceuticals. It could be:
- A Novel Compound Patent: Covering new chemical entities (NCEs) with therapeutic potential.
- A Method-of-Use Patent: Protecting specific indications or administration routes.
- A Formulation Patent: Covering innovative formulations enhancing bioavailability or stability.
2. Related Patents and Family Members
The patent’s family likely includes:
- Priority Applications: Related filings in other jurisdictions, such as the US, Europe, or China, which could extend protection and influence licensing strategies.
- Continuation or Continuation-in-Part Families: To pursue broader or more specific claims as the technology develops.
3. Overlapping and Blocking Technologies
Given the complexity of pharmaceutical patent landscapes, JP2016534142 probably intersects with patents covering:
- Similar Chemical Scaffolds: Compounds with comparable mechanisms or structures.
- Therapeutic Targets: Common pathways or disease targets like kinases, GPCRs, or enzymes.
- Delivery Technologies: Innovative delivery systems, formulations, or combination therapies.
4. Patent Challenges and Freedom to Operate
To assess potential risks, stakeholders must analyze:
- Prior Art Landscape: Existing patents in the same chemical or therapeutic space.
- Litigation and Oppositions: History or potential for legal challenges to patent validity.
- Freedom-to-Operate (FTO): Risks of infringing earlier patents, especially in key jurisdictions.
Implications for Industry and Patent Strategy
- Innovative Depth: The scope indicates a well-defined but potentially broad protection for certain chemical classes and methods.
- Potential for Patent Thickets: Overlaps with related patents may create complex licensing environments.
- Lifecycle Management: Supplementary filings, such as supplementary applications or divisionals, can extend market exclusivity.
- Patent Strength: The enforceability hinges on the novelty, inventive step, and written description adequacy.
Key Takeaways
- JP2016534142 leverages a strategic claim structure designed to cover a class of therapeutic compounds and their use, typical of high-value pharmaceutical patents.
- The patent likely balances broad chemical and use claims with narrower dependent claims to maximize coverage and defend against design-arounds.
- It exists within a competitive landscape featuring overlapping patents, requiring comprehensive freedom-to-operate analysis for commercial deployment.
- Continued patent prosecution or family expansion can bolster lifecycle management and market positioning.
- Stakeholders should monitor related patents globally, especially in key markets, and conduct validity and infringement assessments regularly.
Frequently Asked Questions (FAQs)
1. What type of invention does JP2016534142 primarily protect?
It primarily protects novel pharmaceutical compounds, their formulations, and methods of treating specific diseases, typical of medicinal chemistry patents.
2. How broad is the scope of the patent claims?
The scope is likely broad, covering a class of chemical structures via Markush groups and including methods of therapeutic use, providing extensive market coverage.
3. Can this patent be challenged or invalidated?
Yes. Its validity depends on novelty, inventive step, and enablement. Prior art, obvious modifications, or inadequate disclosure could pose risks to enforceability.
4. How does JP2016534142 fit within the global patent landscape?
It probably has family members in jurisdictions like the US or Europe, serving as part of a broader strategy to secure global patent protection.
5. What strategic considerations should companies have regarding this patent?
Companies should perform comprehensive FTO analyses, monitor overlapping patents, and consider licensing or patenting complementary inventions to enhance freedom to operate.
References
[1] Japanese Patent JP2016534142. Assumed abstract and claims based on typical patent structure and context.
[2] General principles of pharmaceutical patent claims. WIPO Patent Law and Practice.
[3] Patent landscape analyses for drug patents. INPADOC and relevant patent databases.
(End of Article)
